Evidence map›Paper›PMID 8774147›Full record

ArticleThe American journal of pathology1996

Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.

K Washiyama, Y Muragaki, L B Rorke, V M Lee, S C Feinstein, M J Radeke, D Blumberg, D R Kaplan, J Q Trojanowski

Abstract read
In one paragraph

Article in The American journal of pathology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Recent advances in embryonal tumours of the central nervous system.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2005
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Primitive neuroectodermal tumors of the central nervous system.Brain pathology (Zurich, Switzerland) · 1997
    Review
  18. Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1997
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

K WashiyamaDepartment of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA.
Y Muragaki
L B Rorke
V M Lee
S C Feinstein
M J Radeke
D Blumberg
D R Kaplan
J Q Trojanowski
University of Pennsylvania · US

Funding

INTERMEDIATE FILAMENT PROTEINS AS TUMOR MARKERSR01CA036245 · NCI · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 1985 to 1999
–
NEUROFILAMENT EXPRESSION AND TUMOR PROGRESSIONR37CA036245 · NCI · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 1987 to 1995
–
NCI NIH HHS CA-36245-13
6 · The paper itself

Abstract

Primitive neuroectodermal tumors (PNETs) of the central nervous system (CNS) are poorly understood childhood neoplasms, and medulloblastomas are the most common pediatric PNETs. Neoplastic cells in medulloblastomas and other PNETs resemble progenitor cells of the developing central nervous system, but they also may exhibit the molecular phenotype of immature neurons or glia. As neurotrophins play a role in regulating differentiation, proliferation, and cell death in the normal developing central nervous system, and recent evidence suggests that neurotrophins may influence the behavior of medulloblastomas, we studied 29 PNET biopsy samples (27 of which were posterior fossa medulloblastomas) by immunobistochemistry using antibodies specific for each of the major high affinity neurotrophin receptor proteins, ie, TrkA, TrkB, and TrkC. A subset of these tumors also was examined by Western blot. Immunoreactive TrkA, TrkB, and TrkC were observed in neoplastic cells in 8 (27%), 18 (62%), and 14 (48%) of these PNETs, respectively. Additional immunohistochemical studies of a subset of these PNETs using antibodies to neurotrophins that primarily activate TrkB and TrkC, ie, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5, showed that immunoreactive brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 were detected in 22, 9, and 19% of these PNET biopsies, respectively. Finally, 19 pediatric brain tumors other than these PNETs also were studied here, and they expressed these neurotrophins and their receptors to a variable extent. The demonstration here that neurotrophins and their cognate receptor proteins are expressed in PNETs as well as in other pediatric brain tumors may imply that signal transduction pathways mediated by neurotrophins and/or their receptors influence the induction or progression of these common childhood neoplasms.

Indexed as

AdolescentBlotting, WesternBrain NeoplasmsChildChild, PreschoolFemaleHumansInfantMaleMedulloblastomaNerve Growth FactorsNeuroectodermal Tumors, Primitive, PeripheralReceptor, Ciliary Neurotrophic FactorReceptor Protein-Tyrosine KinasesReceptors, Nerve Growth FactorReceptor, trkANerve Growth FactorsReceptor, Ciliary Neurotrophic FactorReceptor Protein-Tyrosine KinasesReceptors, Nerve Growth FactorReceptor, trkAReceptor, trkC

Identifiers

PMID8774147
PMCPMC1861715
OpenAlexW274031538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.